Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 24007454)

1.

Clinical evaluation of the ADE scorecards as a decision support tool for adverse drug event analysis and medication safety management.

Hackl WO, Ammenwerth E, Marcilly R, Chazard E, Luyckx M, Leurs P, Beuscart R.

Br J Clin Pharmacol. 2013 Sep;76 Suppl 1:78-90. doi: 10.1111/bcp.12185.

2.

Evaluation of a Clinical Decision Support Rule-set for Medication Adjustments in mHealth-based Heart Failure Management.

Kropf M, Modre-Osprian R, Gruber K, Fruhwald F, Schreier G.

Stud Health Technol Inform. 2015;212:81-7.

PMID:
26063261
3.

Decision Analysis for Metric Selection on a Clinical Quality Scorecard.

Guth RM, Storey PE, Vitale M, Markan-Aurora S, Gordon R, Prevost TQ, Dunagan WC, Woeltje KF.

Am J Med Qual. 2015 Jun 2. pii: 1062860615589117. [Epub ahead of print]

PMID:
26038608
4.

Adverse Drug Event Prevention: 2014 Action Plan Conference.

Ducoffe AR, Baehr A, Peña JC, Rider BB, Yang S, Hu DJ.

Am J Med Qual. 2015 May 29. pii: 1062860615588105. [Epub ahead of print]

PMID:
26024666
5.

Impact of a Swiss adverse drug event prevention collaborative.

Staines A, Mattia C, Schaad N, Lécureux E, Bonnabry P.

J Eval Clin Pract. 2015 May 26. doi: 10.1111/jep.12376. [Epub ahead of print]

PMID:
26011777
6.

Assessing the potential adoption and usefulness of concurrent, action-oriented, electronic adverse drug event triggers designed for the outpatient setting.

Mull HJ, Rosen AK, Shimada SL, Rivard PE, Nordberg B, Long B, Hoffman JM, Leecaster M, Savitz LA, Shanahan CW, Helwig A, Nebeker JR.

EGEMS (Wash DC). 2015 Apr 30;3(1):1116. doi: 10.13063/2327-9214.1116. eCollection 2015.

7.

Development of an advanced clinical decision support system on medication safety.

Ibáñez-García S, Herranz-Alonso A, de la Rosa JL, Rodríguez-González CG, Martín-Barbero ML, Sanjurjo-Sáez M.

Stud Health Technol Inform. 2015;210:968-9. No abstract available.

PMID:
25991318
8.

Exploring adverse drug events at the class level.

Winnenburg R, Sorbello A, Bodenreider O.

J Biomed Semantics. 2015 May 1;6:18. doi: 10.1186/s13326-015-0017-1. eCollection 2015.

9.

Pediatric medication error reports in Korea adverse event reporting system database, 1989-2012: comparing with adult reports.

Woo Y, Kim HE, Chung S, Park BJ.

J Korean Med Sci. 2015 Apr;30(4):371-7. doi: 10.3346/jkms.2015.30.4.371. Epub 2015 Mar 19.

10.

3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.

Vilar S, Tatonetti NP, Hripcsak G.

Sci Rep. 2015 Mar 6;5:8809. doi: 10.1038/srep08809.

11.
12.

Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.

Hébert G, Netzer F, Ferrua M, Ducreux M, Lemare F, Minvielle E.

Eur J Cancer. 2015 Feb;51(3):427-35. doi: 10.1016/j.ejca.2014.12.002. Epub 2014 Dec 27.

PMID:
25549531
13.

[Developing a terminology in the French language for clinical practice and research in drug safety].

Roulet L, Ballereau F, Lapeyre-Mestre M, Joris-Frasseren M, Asseray N.

Therapie. 2015 May-Jun;70(3):283-92. doi: 10.2515/therapie/2014215. Epub 2014 Dec 24. French.

PMID:
25534521
14.

From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.

Koutkias VG, McNair P, Kilintzis V, Skovhus Andersen K, Niès J, Sarfati JC, Ammenwerth E, Chazard E, Jensen S, Beuscart R, Maglaveras N.

Methods Inf Med. 2014;53(6):482-92. doi: 10.3414/ME14-01-0027. Epub 2014 Nov 7.

PMID:
25377477
15.

An internal quality improvement collaborative significantly reduces hospital-wide medication error related adverse drug events.

McClead RE Jr, Catt C, Davis JT, Morvay S, Merandi J, Lewe D, Stewart B, Brilli RJ; Adverse Drug Event Quality Collaborative.

J Pediatr. 2014 Dec;165(6):1222-1229.e1. doi: 10.1016/j.jpeds.2014.08.063. Epub 2014 Oct 8.

PMID:
25304926
16.

Similarity-based modeling applied to signal detection in pharmacovigilance.

Vilar S, Ryan PB, Madigan D, Stang PE, Schuemie MJ, Friedman C, Tatonetti NP, Hripcsak G.

CPT Pharmacometrics Syst Pharmacol. 2014 Sep 24;3:e137. doi: 10.1038/psp.2014.35.

17.

Concordance and predictive value of two adverse drug event data sets.

Cami A, Reis BY.

BMC Med Inform Decis Mak. 2014 Aug 22;14:74. doi: 10.1186/1472-6947-14-74.

18.

Choosing to avoid poor-quality healthcare.

[No authors listed]

Prescrire Int. 2014 Jun;23(150):144. No abstract available.

PMID:
25121143
19.

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.

de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

Health Qual Life Outcomes. 2014 Aug 13;12:103. doi: 10.1186/s12955-014-0103-6.

20.

Knowledge discovery of drug data on the example of adverse reaction prediction.

Yildirim P, Majnarić L, Ekmekci O, Holzinger A.

BMC Bioinformatics. 2014;15 Suppl 6:S7. doi: 10.1186/1471-2105-15-S6-S7. Epub 2014 May 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk